Together Pharma Ltd
TGPHF · OTC
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
|---|---|---|---|---|
| Revenue | $25,201 | $25,201 | $22,743 | $22,743 |
| % Growth | 0% | 10.8% | 0% | – |
| Cost of Goods Sold | $15,620 | $15,620 | $13,986 | $13,986 |
| Gross Profit | $9,581 | $9,581 | $8,757 | $8,757 |
| % Margin | 38% | 38% | 38.5% | 38.5% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2,145 | $2,145 | $1,635 | $1,635 |
| SG&A Expenses | $3,372 | $3,372 | $3,127 | $3,127 |
| Sales & Mktg Exp. | $1,227 | $1,227 | $1,492 | $1,492 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,372 | $3,372 | $3,127 | $3,918 |
| Operating Income | $6,210 | $6,210 | $5,630 | $5,630 |
| % Margin | 24.6% | 24.6% | 24.8% | 24.8% |
| Other Income/Exp. Net | -$1,156 | -$1,156 | -$7,301 | -$7,301 |
| Pre-Tax Income | $5,054 | $5,054 | -$1,671 | -$1,671 |
| Tax Expense | $1,376 | $1,376 | $1,977 | $1,977 |
| Net Income | $3,182 | $3,182 | -$4,461 | -$4,461 |
| % Margin | 12.6% | 12.6% | -19.6% | -19.6% |
| EPS | 0.28 | 0.28 | -0.51 | -0.51 |
| % Growth | 0% | 154.9% | 0% | – |
| EPS Diluted | 0.25 | 0.25 | -0.51 | -0.51 |
| Weighted Avg Shares Out | 11,571 | 11,571 | 8,785 | 8,785 |
| Weighted Avg Shares Out Dil | 12,704 | 12,704 | 8,785 | 8,785 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $8,832 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $1,401 | $1,401 | $565 | $565 |
| EBITDA | $7,610 | $7,610 | $6,195 | $6,195 |
| % Margin | 30.2% | 30.2% | 27.2% | 27.2% |